Filing Details
- Accession Number:
- 0001104659-19-052675
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-10-02 18:18:41
- Reporting Period:
- 2019-10-01
- Accepted Time:
- 2019-10-02 18:18:41
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1121702 | Yield10 Bioscience Inc. | YTEN | Miscellaneous Plastics Products (3080) | 043158289 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1377830 | P Oliver Peoples | C/O Yield10 Bioscience, Inc. 19 Presidential Way Woburn MA 01801 | Pres & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2019-10-01 | 9,178 | $0.56 | 66,806 | No | 4 | P | Direct | |
Common Stock | Acquisiton | 2019-10-02 | 822 | $0.53 | 67,628 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 24,124 | Indirect | By 401(k) Plan |
Footnotes
- These shares were purchased pursuant to a Rule 10b5-1 buying plan adopted by the reporting person on June 3, 2019.
- Represents the weighted average sales price for the shares purchased. Sales prices for this transaction ranged from $0.53 to $0.56. The reporting person undertakes to provide, upon request by the Securities and Exchange Commission staff, Yield10 Bioscience, Inc., or a security holder of Yield10 Bioscience, Inc., full information regarding the number of shares purchased at each separate price.
- Represents the weighted average sales price for the shares purchased. Sales prices for this transaction ranged from $0.53 to $0.535. The reporting person undertakes to provide, upon request by the Securities and Exchange Commission staff, Yield10 Bioscience, Inc., or a security holder of Yield10 Bioscience, Inc., full information regarding the number of shares purchased at each separate price.
- These shares were acquired as Company matching contributions under the Yield10 Bioscience, Inc. 401(k) Plan.